Roger Mack Hinson - 01 Mar 2022 Form 4 Insider Report for MEDNAX, INC. (MD)

Role: Pres., PDX & OBX Medical Group
Signature: /s/ Dominic J. Andreano, Attorney-in-Fact
Issuer symbol: MD
Transactions as of: 01 Mar 2022
Net transactions value: -$240,427
Form type: 4
Filing time: 03 Mar 2022, 16:01:09 UTC
Previous filing: 10 Nov 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MD	Common Stock	Tax liability	$240,427	-10,244	-8.6%	$23.47	109,457	01 Mar 2022	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents 10,244 restricted shares withheld for payment of taxes upon vesting of shares.
F2	Includes 12,246 restricted shares granted pursuant to the Issuer's Amended and Restated 2008 Incentive Compensation Plan in connection with achievement in excess of target of specified performance-based criteria for the performance period from January 1, 2021 through December 31, 2021. Also includes 64 shares acquired by reporting person through Issuer's Employee Stock Purchase Plan since the last Form 4 filing.

Content

Represents 10,244 restricted shares withheld for payment of taxes upon vesting of shares.

Includes 12,246 restricted shares granted pursuant to the Issuer's Amended and Restated 2008 Incentive Compensation Plan in connection with achievement in excess of target of specified performance-based criteria for the performance period from January 1, 2021 through December 31, 2021. Also includes 64 shares acquired by reporting person through Issuer's Employee Stock Purchase Plan since the last Form 4 filing.